Humana Inc. (NYSE:HUM) Shares Sold by Kingfisher Capital LLC

Kingfisher Capital LLC cut its stake in Humana Inc. (NYSE:HUM) by 11.8% in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 4,329 shares of the insurance provider’s stock after selling 577 shares during the period. Kingfisher Capital LLC’s holdings in Humana were worth $1,371,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors also recently bought and sold shares of HUM. Pzena Investment Management LLC raised its holdings in shares of Humana by 538.7% in the second quarter. Pzena Investment Management LLC now owns 2,318,347 shares of the insurance provider’s stock worth $866,250,000 after buying an additional 1,955,375 shares during the last quarter. Marshall Wace LLP raised its stake in Humana by 118.9% in the 2nd quarter. Marshall Wace LLP now owns 1,425,302 shares of the insurance provider’s stock worth $532,564,000 after acquiring an additional 774,085 shares during the last quarter. International Assets Investment Management LLC raised its stake in Humana by 261,025.1% in the 3rd quarter. International Assets Investment Management LLC now owns 738,984 shares of the insurance provider’s stock worth $2,340,660,000 after acquiring an additional 738,701 shares during the last quarter. FMR LLC lifted its position in Humana by 23.4% during the 3rd quarter. FMR LLC now owns 3,388,859 shares of the insurance provider’s stock worth $1,073,387,000 after acquiring an additional 643,291 shares during the period. Finally, Baupost Group LLC MA purchased a new stake in Humana during the 2nd quarter valued at about $156,933,000. 92.38% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of equities research analysts recently commented on the company. Barclays lifted their target price on Humana from $250.00 to $253.00 and gave the stock an “equal weight” rating in a report on Thursday, October 31st. Piper Sandler cut shares of Humana from an “overweight” rating to a “neutral” rating and decreased their price objective for the company from $392.00 to $274.00 in a research note on Thursday, October 3rd. Truist Financial cut their price objective on shares of Humana from $400.00 to $260.00 and set a “hold” rating on the stock in a research note on Friday, October 11th. Deutsche Bank Aktiengesellschaft decreased their target price on shares of Humana from $349.00 to $250.00 and set a “hold” rating for the company in a research report on Thursday, October 3rd. Finally, UBS Group cut their price target on Humana from $380.00 to $250.00 and set a “neutral” rating on the stock in a research report on Friday, October 4th. Twenty analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. According to MarketBeat.com, Humana has a consensus rating of “Hold” and a consensus target price of $315.86.

Humana Price Performance

NYSE:HUM opened at $296.68 on Friday. The firm has a market cap of $35.72 billion, a P/E ratio of 26.28, a price-to-earnings-growth ratio of 2.34 and a beta of 0.52. The stock has a 50 day moving average of $275.60 and a two-hundred day moving average of $329.77. Humana Inc. has a 12 month low of $213.31 and a 12 month high of $526.47. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.67.

Humana (NYSE:HUM) last posted its quarterly earnings data on Wednesday, October 30th. The insurance provider reported $4.16 EPS for the quarter, beating the consensus estimate of $3.48 by $0.68. Humana had a return on equity of 13.20% and a net margin of 1.18%. The firm had revenue of $29.30 billion during the quarter, compared to the consensus estimate of $28.66 billion. On average, analysts expect that Humana Inc. will post 15.86 earnings per share for the current fiscal year.

Humana Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, January 31st. Investors of record on Tuesday, December 31st will be given a dividend of $0.885 per share. The ex-dividend date of this dividend is Tuesday, December 31st. This represents a $3.54 dividend on an annualized basis and a yield of 1.19%. Humana’s payout ratio is presently 31.36%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.